Point72 Asset Management L.P. Decreases Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Point72 Asset Management L.P. cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 35.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,474,220 shares of the company's stock after selling 808,590 shares during the quarter. Point72 Asset Management L.P. owned approximately 1.59% of Acadia Healthcare worth $58,453,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Wellington Management Group LLP increased its position in Acadia Healthcare by 0.7% in the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after buying an additional 76,490 shares during the last quarter. FMR LLC increased its holdings in Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after acquiring an additional 4,489,681 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Acadia Healthcare by 18.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after acquiring an additional 486,395 shares during the period. JPMorgan Chase & Co. lifted its holdings in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after purchasing an additional 454,044 shares during the last quarter. Finally, Madison Avenue Partners LP bought a new position in Acadia Healthcare during the fourth quarter worth about $76,339,000.

Analyst Ratings Changes

ACHC has been the topic of a number of recent research reports. Mizuho dropped their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 14th. Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. KeyCorp reduced their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Guggenheim started coverage on Acadia Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price objective on the stock. Finally, Barclays cut their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Price Performance

Shares of ACHC stock traded down $1.17 during trading on Wednesday, hitting $24.03. The company had a trading volume of 390,816 shares, compared to its average volume of 1,706,435. The stock's 50-day moving average is $26.06 and its two-hundred day moving average is $35.30. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of 7.92, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same quarter in the prior year, the firm earned $0.84 EPS. The business's revenue for the quarter was up .3% compared to the same quarter last year. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.